来自MSN1 年
Modifying brain molecule relaxin-3 can potentially reduce side effects in treating anxiety ...When relaxin-3 is released in the brain, it binds to a target receptor RXFP3—to trigger a variety of signaling responses among the cells, which affect the body's physiological processes.
Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果